We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FORMA Therapeutics Grants Genentech Exclusive Rights to Acquire a Pre-clinical Cancer Program

News   Jul 14, 2011

 
FORMA Therapeutics Grants Genentech Exclusive Rights to Acquire a Pre-clinical Cancer Program
 
 
 

RELATED ARTICLES

Potential Carcinogen Present in High Levels in E-cigarette Liquids

News

A potential carcinogen called "pulegone" is present in high levels in electronic cigarette liquids and smokeless tobacco products, according to a new study.

READ MORE

Some Cancer Drugs Don’t Work by Hitting Their Targets

News

Some cancer drug candidates in clinical trials kill cancerous cells through off-target effects instead of by interacting with their intended molecular targets, according to new study findings.

READ MORE

Hidden Differences May Help Cells Evade Drug Therapy

News

Seemingly identical cells can use different protein molecules to carry out the same function in an important cellular process. Scientists have named this variability “functional mosaicism”. It could have significant implications for the development of therapeutic treatments.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE